Designation / Description 2B5 MOUSE HYBRIDOMA
U.S. Patent Number
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Animals were immunized with purified high molecular weight kininogen (HMWK) isolated from fresh human plasma.
Spleen cells were fused with Sp2/0-Ag14 myeloma cells.
The antibody is specific for the heavy chain (64000 dalton kallikrein cleavage fragment) of human kininogen.
It does not neutralize the coagulant activity of HMWK.
The affinity (apparent Kd) of 2B5 for HMWK was calculated to be 1.91 nM.
immunoglobulin; monoclonal antibody; against human kininogen heavy chain
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
Shipped frozen
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished.
Basic Documentation

Colman RW, Schmaier AH. Monoclonal antibodies to human kininogen and methods of preparing same. US Patent 4,908,431 dated Mar 13 1990

Colman RW, Schmaier AH. Method for detecting human kininogen using monoclonal antibodies thereto. US Patent 5,047,323 dated Sep 10 1991